title: Survival rate of etanercept for psoriasis in real life: a multicentre observational study.
authors.affiliation: Dermatology Department, Hospital Universitario Virgen de la Victoria, s/n. 29071-Málaga, Spain., Dermatology and Medicine Department, University of Málaga, Spain.
authors.forename: Enrique
authors.initials: E
authors.lastname: Herrera-Acosta
authors.affiliation: Dermatology Department, Hospital Universitario Virgen de la Victoria, s/n. 29071-Málaga, Spain., Dermatology and Medicine Department, University of Málaga, Spain.
authors.forename: Jorge A
authors.initials: JA
authors.lastname: Suárez-Pérez
authors.affiliation: Dermatology and Medicine Department, University of Málaga, Spain.
authors.forename: José
authors.initials: J
authors.lastname: Aguilera
authors.affiliation: Dermatology Department, Hospital Universitario Reina Sofía, Córdoba, Spain.
authors.forename: Francisco
authors.initials: F
authors.lastname: Gómez-García
authors.affiliation: Dermatology Department, Hospital Universitario Reina Sofía, Córdoba, Spain.
authors.forename: Rafael
authors.initials: R
authors.lastname: Jiménez-Puya
authors.affiliation: Dermatology and Pathology Department, Hospital Universitario de Canarias, La Laguna, Spain.
authors.forename: Francisco
authors.initials: F
authors.lastname: Guimerá
authors.affiliation: Dermatology Department, Hospital Universitario Virgen de la Victoria, s/n. 29071-Málaga, Spain., Dermatology and Medicine Department, University of Málaga, Spain.
authors.forename: Maria V
authors.initials: MV
authors.lastname: Mendiola
authors.affiliation: Dermatology Department, Hospital Universitario Virgen de la Victoria, s/n. 29071-Málaga, Spain., Dermatology and Medicine Department, University of Málaga, Spain.
authors.forename: Enrique
authors.initials: E
authors.lastname: Herrera-Ceballos
mesh_terms: D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000627:therapeutic use*; D000068800:Etanercept; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects / Q000627:therapeutic use*; D053208:Kaplan-Meier Estimate; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy*; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*; D012189:Retrospective Studies; D012720:Severity of Illness Index; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept